SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Momenta Pharmaceuticals Inc.
An SI Board Since March 2004
Posts SubjectMarks Bans Symbol
3027 64 0 MNTA
Emcee:  michael_f_murphy Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
2127Great,,,,,,,they drop the news late Friday afternoon after knowing this event thArthur Radley-12/18/2009
2126249 was dropped a year ago ($10M of the milestones). 178 today ($15M). rkrw-12/18/2009
2125I have been sellers of those puts (Jan 7.50 and 10)- not in the volume shown. IRocky9-12/16/2009
2124Appears to me that the option activity was on the Jan $7.50 and $10.00 puts.....Arthur Radley-12/16/2009
2123Canaccord very recently made a bold call expecting approval very early in 2010, rkrw-12/16/2009
2122Options - any idea why they have gone sky high today?Rocky9-12/16/2009
2121What we don't know is how many of his roughly 1M MNTA shares he still owns.DewDiligence_on_SI-12/15/2009
2120FWIW he steps down from mnta and steps up to Millipore. Dr. Robert Langer Joinrkrw-12/15/2009
2119<i>>…[Teva’s] anecdote about the Natco Pharma product was entirely irreDewDiligence_on_SI-12/9/2009
2118Background info on the shelf registration: siliconinvestor.com Updated ‘ReadMeFDewDiligence_on_SI-12/9/2009
2117Fair comment. Perhaps I should have said that the anecdote about the Natco Pharnigel bates-12/9/2009
2116MNTA filed a $150MM shelf offering. Not on Yahoo yet - Schwab is showing. EditRocky9-12/9/2009
2115>>if current analytical methods 'aren't capable of characterizing Biomaven-12/9/2009
2114>>...Teva asserts that generic companies can't show their versions arenigel bates-12/8/2009
2113The coincident timing of Teva’s CP resubmission and Teva’s withdrawn claim of stDewDiligence_on_SI-12/7/2009
2112This was issued 11/27... By Thomas Gryta Of DOW JONES NEWSWIRES NEW YORK (DoArthur Radley-12/7/2009
2111Update on Copaxone patent case: • Teva has dropped its claim that NVS stole TevDewDiligence_on_SI-12/7/2009
2110MNTA ‘ReadMeFirst’ updated: <i>recent analyst reports by Leerink Swann, WDewDiligence_on_SI-12/7/2009
2109Yeah...but stock sure hasn't acted as EXPECTED. (:<)Arthur Radley-12/1/2009
2108But I thought the MNTA news is plausible and <b>expected</b> ? :)nigel bates212/1/2009
2107thestreet.com MNTA, ELN, and King Pharm.........??????Arthur Radley-11/30/2009
2106MNTA: Upgraded - JAGNote by Oppenheimer & Co. Inc. 8:04 am ET 11/19/2009- JAArthur Radley-11/19/2009
2105Thanks, Cary (eom)DewDiligence_on_SI-11/18/2009
2104fiercebiotech.com MNTA covered.......positive comments.Arthur Radley-11/18/2009
2103Teva amends Copaxone suit against MNTA/NVS: siliconinvestor.comDewDiligence_on_SI-11/10/2009
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News